← Photo Competition “Health Law” Deadline: 15 March 2011Open to: candidates with strong academic abilities and a Master’s degreeScholarship: 1250 Euros/month for 36 months for PhDThe Bremen International Graduate School of Social Sciences (BIGSSS) invites applications to its Ph.D. program. The program will commence on September 1st, 2011.15 Successful applicants for the Ph.D. and Post-doc fellowships will pursue a topic in one of BIGSSS’ five Thematic Fields: * Thematic Field 1:Global Integration* Thematic Field 2:Integration and Diversity in the New Europe* Thematic Field 3:Social Integration and the Welfare State* Thematic Field 4:Attitude Formation, Value Change and Intercultural Communication* Thematic Field 5:Life-Course and Lifespan DynamicsEligibility* An excellent MA degree (or national equivalents like the German “Diplom” or “Magister”) in a discipline pertinent to at least one of BIGSSS’ five Thematic fields (see above), i.e. in Political Science (including related degree programs in European Studies or International Relations), Sociology, Psychology, Law, Economics or Mass Communication. The degree must be completed by the end of July of the year of application, which means you may apply before having finished your MA degree.* English proficiency as described in the application materials section below.* Additionally BIGSSS offers 2 Preparatory Fellowships to particularly talented BA Graduates. Please refer to Preparatory Fellowships to find out more about the program.ScholarshipsBIGSSS offers 15 Ph.D. stipends of 1250 Euros/month for 36 months, contingent on successful completion of each year. To support its Ph.D. fellows in achieving early scientific independence, it also provides funds for conducting, presenting and publishing research. There is no separate funding application, because all admitted applicants receive a stipend.Application ProcessApply online here.More about application materialsThe application period for the Fall 2011 semester will begin in the middle of December 2010 and go until March 15th, 2011. The deadline refers to the date of receipt of the application. All letters of recommendation must also reach BIGSSS by March 15th, 2011.The official webpage. Share 0 Tweet Reddit Similar Stories Pocket LinkedIn 0 10 PhD positions at the Bremen International Graduate School of Social Sciences Leave a Reply Cancel ReplyYou must be logged in to post a comment. 15 PhD in Social Sciences, Germany Apply for PhD Scholarships in Bremen TYE – Tools for Youth Exchanges, Iceland → January 18, 2011 Published by Site Default +1 Apply for BIGSSS Summer School Program
narvikk/iStockBy MORGAN WINSOR, ERIN SCHUMAKER, IVAN PEREIRA and EMILY SHAPIRO, ABC News(NEW YORK) — A pandemic of the novel coronavirus has now infected more than 64 million people and killed over 1.4 million worldwide, according to real-time data compiled by the Center for Systems Science and Engineering at Johns Hopkins University.Here’s how the news developed Wednesday. All times Eastern:Dec 02, 8:50 pmFauci predicts US ‘close to normal’ by summer if 70% vaccinatedDr. Anthony Fauci spoke to ABC News Live anchor Linsey Davis Wednesday about the latest developments in the coronavirus vaccine.The director of the National Institute of Allergy and Infectious Diseases said he was pleasantly surprised at the high efficacy rate of the Moderna and Pfizer vaccines.“You know, 94% and 95% is almost as good as it gets,” he told ABC News Live. “That’s almost as good as measles, which is the gold standard of a highly effective vaccine.”When asked when Americans are likely to see things returning to normal, Fauci said at least 70% of the population would have to be vaccinated.“If we can do that, we can get a blanket of immunity over this country that as we get into summer and early fall, we could be very close to normal,” he said.Fauci reiterated that Americans need to continue to adhere to health guidelines to slow the spread of the virus over the next couple of months. He again recommended that people curtail travel and avoid crowds during the holidays.“Any kind of congregate settings where you have large numbers of people indoors particularly without masks is a very risky situation,” Fauci said. “It doesn’t matter where you are, who you are or where you’re doing it — it’s a risky situation.”-ABC News’ Haley YamadaDec 02, 8:36 pmUS records 2nd-highest daily death count everThe U.S. recorded 2,733 deaths on Wednesday, the U.S. COVID Tracking Project reported, the second-highest total since the pandemic began.The only higher total was record during the previous height of the pandemic on May 7, when 2,769 Americans died of coronavirus-related issues, according to the tracking project.“It is also the first time deaths have exceeded 5k in a 2-day period,” the project tweeted.The seven-day average for deaths is at 1,584, according to the health data.Hospitalizations in the country passed another grim milestone, as over 100,000 people are in hospitals for COVID-19 symptoms, according to the data. The seven-day average for hospitalizations is at 95,314, The COVID Tracking Project said.Dec 02, 8:15 pmUS records 2nd-highest daily death count everThe U.S. recorded 2,733 deaths on Wednesday, the U.S. COVID Tracking Project reported, the second-highest total since the pandemic began.The only higher total was record during the previous height of the pandemic on May 7, when 2,769 Americans died of coronavirus-related issues, according to the tracking project.“It is also the first time deaths have exceeded 5,000.The seven-day average for deaths is at 1,584, according to the health data.Hospitalizations in the country passed another grim milestone, as over 100,000 people are in hospitals for COVID-19 symptoms, according to the data. The seven-day average for hospitalizations is at 95,314, The COVID Tracking Project said.Dec 02, 7:07 pmICU occupancy surging in several states: HHSAbout 30% of hospitals across the country have more than 80% of their intensive care unit beds filled, according to an internal memo by the U.S. Department of Health and Human Services obtained by ABC News.Roughly 21% of all hospital patients nationwide have COVID-19, which is just 3 percentage points lower than the all-time peak, according to HHS.The memo said 30% of ventilators in use are occupied by coronavirus patients.Several states have seen record-level hospitalization levels in the last week, according to HHS.On Nov. 30, Arkansas recorded 1,063 COVID-19 active hospitalizations, 107 COVID-19 patients admitted to the ICU and 211 COVID-19 patients on ventilators, the memo said.In the week ending Nov. 29, hospital occupancy in Louisiana averaged 64.2% for inpatient beds and 70.7% for adult ICU beds, HHS said.ICU utilization in New Mexico averaged 95% in that same period, according to the memo.-ABC News’ Josh MargolinDec 02, 7:01 pmEPA chief quarantining after COVID exposureEnvironmental Protection Agency Administrator Andrew Wheeler announced he is quarantining after he was exposed to a person who tested positive for the coronavirus.“He was exposed to an individual who at the time of exposure had not yet tested positive, was wearing a mask, and was/still is asymptomatic,” EPA spokesman James Hewitt said in a statement.Wheeler was slated to speak at the Nixon Library tomorrow for EPA’s 50th anniversary, but he said he will give the address virtually.-ABC News’ Stephanie EbbsDec 02, 6:59 pm48 NBA players test positive in 1st round of resultsThe NBA and NBA Players Association announced the first results of coronavirus testing among players in the lead-up to its shortened season starting later this month.The league and union said 48 of the 546 players tested, roughly 8.8%, had positive results. Any player who tested positive will be quarantined away from teammates as training camps begin to open.In March the NBA became the first American professional sports league to suspend its season after a player on the Utah Jazz contracted the virus. The suspension of the season, and eventual cancellation, started a domino effect among sports across the country. Games restarted in July under a “bubble” at Orlando’s Wide World of Sports Complex. The Los Angeles Lakers won the title in October.The 2020-2021 season is slated to begin Dec. 22 and will not take place in a “bubble.”Dec 02, 5:49 pmModerna to begin vaccine testing on childrenModerna announced in a filing with the federal government that it will begin recruiting volunteers between 12 and 18 years old to participate in its coronavirus vaccine trials.This listing doesn’t say when Moderna will start its trials in children.It’s common in clinical trials to start with adults and then when the safety profile has been established to add more populations like children and pregnant women.Pfizer has already started recruiting, enrolling and testing its vaccine on children as young as 12 years old.-ABC News’ Eric StraussDec 02, 5:15 pmHHS purchases 650K courses of antibody treatmentThe White House and U.S. Department of Health and Human Services announced they’ve purchased over 650,000 courses of of Eli Lilly’s monoclonal antibody treatment for high-risk patients.The treatment, bamlanivimab, can reduce the risk of severe coronavirus symptoms before someone becomes hospitalized.The treatment will be deployed in December and January and complement the 300,000 doses that are currently being distributed, according to HHS.Eli Lilly received emergency use authorization for bamlanivimab from the Food and Drug Administration last month.-ABC News’ Stephanie EbbsDec 02, 4:06 pmTexas to get over 1.4 million vaccine doses in DecemberTexas Gov. Greg Abbott said the CDC is allocating over 1.4 million vaccine doses for the state for December.The doses are expected to arrive the week of Dec. 14, he said Wednesday.“Additional allotments may be made later this month for December,” Abbott said, and “increased allotments are expected in January and the following months.”Meanwhile, California Gov. Gavin Newsom said his state will receive 327,000 doses of the Pfizer vaccine in mid-December.New York Gov. Andrew Cuomo said Wednesday he expects the state to receive 170,000 doses of Pfizer’s vaccine on Dec. 15 if all safety and efficacy approvals are granted. Cuomo said he expects additional doses of Pfizer’s vaccine as well as initial allocations of Moderna’s vaccine, if approved, later this month.Dec 02, 4:06 pmObama says he’ll ‘absolutely’ get vaccine if Fauci says it’s safeFormer President Barack Obama said he will “absolutely” get the vaccine if Dr. Anthony Fauci says it’s safe to take, and Obama said he may even have cameras present for the moment to demonstrate to the public that he trusts the science.“People like Anthony Fauci, who I know, and I’ve worked with, I trust completely. So if Anthony Fauci tells me this vaccine is safe, and can vaccinate, you know, immunize you from getting COVID, absolutely, I’m going to take it,” Obama told SiriusXM host Joe Madison.“I may end up taking it on TV or having it filmed, just so that people know that I trust this science, and what I don’t trust is getting COVID,” he continued. “I think at this point, particularly in the African American community, we are — African Americans, Hispanics, Native Americans — we have the highest death rates from this thing, and are most exposed and most vulnerable, in part because we have a lot of preexisting conditions.”-ABC News’ Ben GittlesonDec 02, 3:14 pmNext 3 months ‘most difficult time’ in US health history: CDC directorCDC Director Robert Redfield said he believes December, January and February will “be the most difficult time in the public health history of this nation.”“December and January and February are going to be rough times,” Redfield said at a virtual Chamber of Commerce event. “Largely because of the stress that it’s going to put on our health care system.”Redfield said he anticipates another 150,000 to 200,000 deaths by February. That would bring the COVID-19 death toll to at least 422,000 Americans.Dec 02, 2:19 pm2 arrested for flying after allegedly knowing they tested positiveTwo residents of the Hawaii island of Kauai were arrested for flying home when they allegedly knew they had tested positive for COVID-19, said Kauai Mayor Derek Kawakami.They were arrested by Kauai police for “second-degree reckless endangering,” Kawakami said.Kauai has seen an “unprecedented surge” in cases, the mayor said. As of Tuesday, the island had 16 active cases, according to the Health Department.Dec 02, 1:50 pmNext 3 months ‘most difficult time’ in US health history: CDC directorCDC Director Robert Redfield said he believes December, January and February will “be the most difficult time in the public health history of this nation.”“December and January and February are going to be rough times,” Redfield said at a virtual Chamber of Commerce event, Politico reported. “Largely because of the stress that it’s going to put on our health care system.”Dec 02, 12:49 pmNY expects to get 170,000 doses of Pfizer’s vaccine in weeksNew York Gov. Andrew Cuomo said he expects the state to receive 170,000 doses of Pfizer’s vaccine on Dec. 15 if all safety and efficacy approvals are granted.Cuomo said he expects additional doses of Pfizer’s vaccine as well as initial allocations of Moderna’s vaccine, if approved, later this month.Cuomo says effective widespread immunization could take until June through September.Meanwhile, Cuomo says New York faces “another mountain” in the fight against rising cases and hospitalizations.The governor reiterated that small gatherings are the No. 1 cause of COVID-19 spread in the state.Of the over 193,000 tests reported in New York on Tuesday, 4.63% were positive, Cuomo said.-ABC News’ J. Gabriel WareDec 02, 12:08 pmCDC announces alternatives to 14-day quarantineThe Centers for Disease Control and Prevention on Wednesday announced alternatives to its two-week recommended quarantine for people who have been exposed to COVID-19. Quarantine can now end after 10 days without a test if the individual has not reported any symptoms, or after seven days with a negative COVID-19 test and no reported symptoms, said Henry Walke, the CDC’s COVID-19 incident manager. Walke said the move “may make it easier for people to take this critical public health action by reducing the economic hardship associated with a longer period, especially if they cannot work during that time.”People should continue to monitor for symptoms for the full 14 days after being exposed to the virus “especially if quarantine is discontinued early,” he said.A 14-day quarantine remains the best way to prevent spread, according to the CDC.Walke added, “Everyone should follow this specific guidance from their local public health authorities about how long they should quarantine.”-ABC News’ Sophie TatumDec 02, 11:26 amRisk at ‘historic high,’ White House Task Force warnsIn this week’s briefing for governors, the White House Coronavirus Task Force urged all Americans over the age of 65 or with significant health conditions to avoid “any indoor public spaces where anyone is unmasked.”The briefing said those under 40 years old who saw anyone outside their household for Thanksgiving should assume they’re infected and must isolate.“The COVID risk to all Americans is at a historic high,” according to the briefing, which was obtained by ABC News. “The national daily COVID incidence after Memorial Day, but before the summer surge, was fewer than 25,000 new cases/day and is now more than 180,000 new cases/day; COVID inpatients then were fewer than 30,000 but are now more than 90,000; fatalities have more than doubled.”“We are in a very dangerous place due to the current, extremely high COVID baseline and limited hospital capacity; a further post-Thanksgiving surge will compromise COVID patient care, as well as medical care overall,” the briefing said.-ABC News’ Josh Margolin and Brian HartmanDec 02, 9:08 amLarge-scale vaccinations to begin in Russia next week, Putin saysRussian President Vladimir Putin said Wednesday that large-scale COVID-19 vaccinations will begin in Russia next week.Dec 02, 7:42 amOperation Warp Speed’s chief science adviser hopes Pfizer/BioNTech vaccine is approved next weekDr. Moncef Slaoui, chief science adviser to Operation Warp Speed, said he expects the U.S. Food and Drug Administration “to reach a similar conclusion” to the United Kingdom’s approval of a COVID-19 vaccine developed by U.S. pharmaceutical giant Pfizer and its German partner BioNTech.“I hope by the 10th or 11th of December the Pfizer vaccine is approved,” Slaoui told ABC News chief anchor George Stephanopoulos in an interview Wednesday on Good Morning America.Slaoui urged Americans to “listen to the experts” and trust the vaccine approval process.“No corners have been cut,” he said. “The [vaccine] development has been done very quickly because we had great science to allow us to do all the discovery work in weeks rather than in years. And then the clinical work, the most important part that demonstrates the effectiveness of the vaccine and its safety, has been done to a higher standard than what’s done normally in larger number of people but will be assessed and studied in an ongoing basis.”Slaoui described a vaccine as “an insurance against this virus.”“This is what will get us out of the pandemic,” he said.Dec 02, 4:54 amUS reports over 180,000 new casesThere were 180,098 new cases of COVID-19 confirmed in the United States on Tuesday, according to a real-time count kept by Johns Hopkins University.It’s the 29th straight day that the country has reported over 100,000 newly diagnosed infections. Tuesday’s count is down from a peak of 205,557 new cases last Friday.An additional 2,597 fatalities from COVID-19 were also registered nationwide on Tuesday, just under the all-time high of 2,609 new deaths on April 15.COVID-19 data may be skewed in the coming days and weeks due to possible lags in reporting over Thanksgiving followed by a potentially very large backlog from the holiday.A total of 13,725,917 people in the United States have been diagnosed with COVID-19 since the pandemic began, and at least 270,669 of them have died, according to Johns Hopkins. The cases include people from all 50 U.S. states, Washington, D.C. and other U.S. territories as well as repatriated citizens.Much of the country was under lockdown by the end of March as the first wave of pandemic hit. By May 20, all U.S. states had begun lifting stay-at-home orders and other restrictions put in place to curb the spread of the novel coronavirus. The day-to-day increase in the country’s cases then hovered around 20,000 for a couple of weeks before shooting back up over the summer.The numbers lingered around 40,000 to 50,000 from mid-August through early October before surging again to record levels, crossing 100,000 for the first time on Nov. 4 and reaching 200,000 for the first time on Nov. 27.Dec 02, 3:44 amUK authorizes Pfizer/BioNTech vaccine, rollout to begin next weekA COVID-19 vaccine developed by U.S. pharmaceutical giant Pfizer and its German partner BioNTech has been approved for use in the United Kingdom.The U.K. Department of Health and Social Care announced Wednesday that it has accepted the recommendation from the country’s drug regulator to grant a temporary authorization for emergency use of the Pfizer/BioNTech vaccine, called BNT162b2. The Medicines and Healthcare products Regulatory Agency (MHRA) concluded that the vaccine met its standards of safety, quality and effectiveness.“The vaccine will be made available across the U.K. from next week,” a Department of Health and Social Care spokesperson said in a statement, adding that the National Health Service, the publicly-funded healthcare system, “will begin putting their extensive preparations into action to provide care and support to all those eligible for vaccination.”The United Kingdom is the first country in the world to approve the Pfizer/BioNTech vaccine. The companies said in a joint press release Wednesday that they are anticipating further regulatory decisions across the globe in the coming days and weeks and are ready to deliver vaccine doses pending authorizations or approvals.“Today’s Emergency Use Authorization in the U.K. marks a historic moment in the fight against COVID-19,” Pfizer chairman and CEO Albert Bourla said in a statement. “As we anticipate further authorizations and approvals, we are focused on moving with the same level of urgency to safely supply a high-quality vaccine around the world. With thousands of people becoming infected, every day matters in the collective race to end this devastating pandemic.”The MHRA made its recommendation based on a rolling submission, including data from the Phase 3 trial which demonstrated a vaccine efficacy rate of 95%. The Pfizer/BioNTech vaccine was generally well tolerated, with no serious safety concerns reported to date.Pfizer and BioNTech had already agreed to supply the United Kingdom with 40 million doses of BNT162b2 once authorized for emergency use. Now that the vaccine is authorized, the companies will immediately begin delivering doses, the first of which are expected to arrive on U.K. soil in the coming days. The rest of the doses will arrive in stages, with complete delivery fulfillment expected in 2021, according to the press release.Pfizer and BioNTech said the distribution of their vaccine in the United Kingdom will be prioritized according to the populations identified in guidance from the Joint Committee on Vaccination and Immunisation, an independent expert group that advises the U.K. government on immunization.“The Emergency Use Authorization in the U.K. will mark the first time citizens outside of the trials will have the opportunity to be immunized against COVID-19,” BioNTech CEO and co-founder Ugur Sahin said in a statement. “We believe that the roll-out of the vaccination program in the U.K. will reduce the number of people in the high-risk population being hospitalized.”The companies have also filed a request for emergency use authorization with the U.S. Food and Drug Administration and have submitted an application for conditional marketing authorization with the European Medicines Agency.Copyright © 2020, ABC Audio. All rights reserved.
The University of Wisconsin-Madison is engaged in a Title and TotalCompensation (TTC) Project to redesign job titles and compensationstructures. As a result of the TTC project, official job titles oncurrent job postings may change in Fall 2020. Job duties andresponsibilities will remain the same. For more information pleasevisit: https://hr.wisc.edu/title-and-total-compensation-study/.Employment will require a criminal background check. It will alsorequire you and your references to answer questions regardingsexual violence and sexual harassment.The University of Wisconsin System will not reveal the identitiesof applicants who request confidentiality in writing, except thatthe identity of the successful candidate will be released. See Wis.Stat. sec. 19.36(7).The Annual Security and FireSafety Report contains current campus safety and disciplinarypolicies, crime statistics for the previous 3 calendar years, andon-campus student housing fire safety policies and fire statisticsfor the previous 3 calendar years. UW-Madison will provide a papercopy upon request; please contact the University of Wisconsin PoliceDepartment . NegotiableANNUAL (12 months) Employment Class: Principal Duties: Duties will include provision of clinical care of patients,maternity care if applicable, and teaching/supervision of residentsand other learners. Time is available for participation inscholarly work in the candidate’s area(s) of interest.Participation in clinical faculty call schedule, OB call ifapplicable, family practice service schedule, nursing home visits,departmental meetings, and performing administrative duties asnecessary in the position.The preferred candidate will either have experience teaching andworking with a diverse population or will welcome a commitment toteaching and working with a diverse population. A532000-MEDICAL SCHOOL/FAMILY MED/FAMILY MED Full or Part Time: 50% – 100% Ongoing/Renewable Minimum Years and Type of Relevant Work Experience: Job no: 231064-ASWork type: Faculty Full or Part Time, Faculty-Full Time,Faculty-Part TimeDepartment: SMPH/FAMILY MED/FAMILY MEDLocation: MadisonCategories: Health Care, Medical, Social Services Anticipated Begin Date: License or Certificate: Appointment Type, Duration: 231064-AS Additional Information: Degree and Area of Specialization: The Access Wingra Family Medicine Clinic is interested in a FamilyMedicine physician to provide the full spectrum of family medicineskills, with maternity care (OB) optional. This position will alsobe involved in clinical teaching of residents, medical students,and other learners. Applications Open: Jan 30 2021 Central Standard TimeApplications Close: Successful completion of a fully accredited Family MedicineResidency Program.Candidates for associate professor (CHS) or full professor (CHS)rank must meet criteria for appointment at rank per UW School ofMedicine and Public Health guidelines for appointment and promotionon the CHS track. Department(s): Instructions to Applicants: MD or DOFamily Medicine JUNE 01, 2021 Institutional Statement on Diversity: Salary: PROFESSOR (CHS)(D01NN) or ASSOC PROFESSOR (CHS)(D02NN) or ASSTPROFESSOR (CHS)(D03NN) Academic Staff-Renewable Official Title: Sheena [email protected] Access (WTRS): 7-1-1 (out-of-state: TTY: 800.947.3529, STS:800.833.7637) and above Phone number (See RELAY_SERVICE for furtherinformation. ) Contact: Work Type: Position Summary: Wisconsin medical licensure required prior to start date.Certification by or eligible for certification by American Board ofFamily Medicine. Job Number: The successful applicant will be responsible for ensuringeligibility for employment in the United States on or before theeffective date of the appointment.The School of Medicine and Public Health has a deep and profoundcommitment to diversity both as an end in itself but, also as avaluable means for eliminating health disparities. As such, westrongly encourage applications from candidates who foster andpromote the values of diversity and inclusion. The University of Wisconsin is an Equal Opportunity andAffirmative Action Employer. We promote excellence throughdiversity and encourage all qualified individuals to apply.If you need to request an accommodation because of a disability,you can find information about how to make a request at thefollowing website: https://employeedisabilities.wisc.edu/disability-accommodation-information-for-applicants/ Your application must be received through the Jobs at UW portal tobe considered as a candidate. To apply for this position, pleaseclick on the “” button. You will be asked to upload a CV, personalstatement/cover letter, and you will need to provide referencesprior to the interview process.The deadline for assuring full consideration is March 3, 2021,however positions will remain open and applications may beconsidered until the position is filled. Diversity is a source of strength, creativity, and innovation forUW-Madison. We value the contributions of each person and respectthe profound ways their identity, culture, background, experience,status, abilities, and opinion enrich the university community. Wecommit ourselves to the pursuit of excellence in teaching,research, outreach, and diversity as inextricably linkedgoals.The University of Wisconsin-Madison fulfills its public mission bycreating a welcoming and inclusive community for people from everybackground – people who as students, faculty, and staff serveWisconsin and the world.For more information on diversity and inclusion on campus, pleasevisit: Diversity andInclusion
Related The international expansion of the Challenge Family long distance event series continues, with Challenge Family’s newest member – Challenge San Gil Queretaro, taking place over the half distance on 7 June 2015.Challenge San Gil brings the total number of Challenge Family races in Latin America to four, joining Challenge Florianopolis and Challenge Maceio in Brazil and Challenge Ixtapa also in Mexico. There are now 16 races on the American continent, marking Challenge Family’s significant growth in the region.Challenge San Gil is the result of a partnership with the organizers of the popular Triatlon San Gil event, which will be rebranded for 2015.The new event’s stunning location is expected to attract athletes from all over the world, but Challenge San Gil will be particularly targeted at athletes from the United States, Canada, Mexico, and also for Central American athletes.The 1.9K swim will take place in a calm, private lake followed by a demanding 90K bike course, full of spectacular scenery and impressive uphills and descents where athletes are expected to reach high speeds in the final downhill kilometres, making all that climbing through the Queretaro Mountains worthwhile!The flat 21K run is through the residential area of San Gil as well as around the lake before finishing in central San Gil.Since 1991, San Gil has been of Mexico´s top triathlon locations and this triathlon venue is already well known to Mexican triathletes. The State of Querétaro is one of the fastest growing athletic communities in the country.The event venue has a long history hosting Olympic and sprint distances races in the 1990s, and in the past six years the area has seen a promotion of longer distance triathlon events in Mexico.“We’re delighted to join forces with Mario Herrera and his team at this spectacular and well-proven venue,” said Zibi Szlufcik, Challenge Family CEO. “With its stunning course, outstanding quality race delivery and warm Mexican welcome, I have no doubt Challenge San Gil Queretaro will bring a new dimension to long distance triathlon in Mexico.”Querétaro, also known as ‘Santiago de Querétaro’, is located 190 kilometres north of Mexico City. It is a colonial tourism destination with lots of attractions for triathletes and their families. San Gil also has San Juan del Río city nearby where many of the hotels in this municipality are found in luxurious colonial haciendas.www.challenge-sangil.com
First DCA has an openingThe First District Court of Appeal Judicial Nominating Commission is now accepting applications for a vacancy on the First DCA brought about by the resignation of Judge Paul M. Hawkes.Applicants must have been members of The Florida Bar for the preceding 10 years, registered voters, and residents of the territorial jurisdiction of the court at the time of assuming office.Applications can be downloaded from The Florida Bar at www.floridabar.org. An original and three copies of the completed application and attachments must be delivered to Michael J. Glazer, JNC Chair, c/o Ausley & McMullen, 123 S. Calhoun Street, P.O. Box 391 (32302), Tallahassee 32301, no later than noon EDT on December 15. It is requested, but not required, that an additional copy of the application and attachments be provided in an electronic format on either CD or flash drive. This e-copy is not in lieu of paper copies. First DCA has an opening December 1, 2011 Regular News
Share on Twitter Email Many people report persisting positive effects after receiving ibogaine-assisted detoxification for opioid addiction, but many patients not be receiving adequate support after the treatment, according to new research published in the Journal of Psychoactive Drugs.Ibogaine a psychoactive substance found in the root bark of the African Tabernanthe iboga plant, and research suggests that the substance can help treat opioid withdrawal and cravings.“I was interested in this topic because of the growing body of evidence that suggests that ibogaine might be useful for some people with opioid use disorders,” explained Alan Kooi Davis, a research fellow at Johns Hopkins Behavioral Pharmacology Research Unit and the corresponding author of the study. Share on Facebook LinkedIn Share Pinterest “Although I am skeptical about whether it would ever become available in the US, many people travel abroad to seek this treatment in countries where it is unregulated, and conducting a study to examine the experiences of this type of unregulated treatment is an important step towards understanding under what conditions it may be helpful.” The researchers surveyed 73 people who received one week of detoxification treatment with ibogaine at a clinic in Mexico between 2012 and 2015. Most of the participants had been using heroin or prescription opioids for at least four years.Many of the respondents (45%) reported a decrease in opioid use after the treatment, while 36% reported never using opioids again and 15% reported no change in their opioid use. Four percent reported an increase in opioid use.Most of the participants believed that ibogaine treatment had resulted in positive changes in psychological, behavioral, and social functioning. But many of the participants also reported having trouble incorporating their ibogaine experience into their daily lives.“Ibogaine-assisted detoxification, like any other potential treatment for addiction, is not a magic bullet. Not only do most people relapse (which is similar to other treatments) but there is an increase in risk associated with traveling to a country where this treatment is unregulated. We found that participants noted difficulties associated with this process, including coming back home and lacking support from the facilities they had traveled to,” Davis told PsyPost.“Without adequate support following this treatment, it is quite difficult for people to be successful in their recovery from opioid addiction. Nevertheless, for those that are able to maintain abstinence or reduce their opioid use, they reported improvements in overall health, mood, and their sense of positive motions/perspectives in life, which they attributed at least in part to their ibogaine treatment.”Those who responded to the treatment reported “significantly greater positive changes in their sense of gratitude, ability to be a more authentic person, sense of meaning in life, appreciation for life, experience of inner peace, feelings of love and openheartedness, experience of joy or bliss, experience of sacredness in daily life, ability to tolerate difficult or painful feelings, and capacity for coping with stress.”Though ibogaine has shown some promise to help fight addiction, research on the substance is still in the beginning stages.“There is much to be learned about this treatment. Many potential dangers associated with the context and acute effects of the substance,” Davis said. “And people should be very cautious about whether to consider this treatment in a foreign country. Until such time as large-scale randomized controlled trials can be conducted, the evidence that we reported in this paper should be considered preliminary.”The study, “A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification“, was authored by Alan K. Davis, Elise Renn, Austin-Marley Windham-Herman, Martin Polanco, and Joseph P. Barsuglia.
Nov 14, 2011Indonesia confirms H5N1 death in mother of 2 earlier victimsIndonesia’s Ministry of Health has confirmed H5N1 avian flu in the death of a 29-year-old mother of two children who also died of the disease, according to a report today from Bird Flu Information Corner, an Internet message board operated by Kobe University in Japan and Airlangga University in Indonesia. The report said the patient, from the resort island of Bali, felt weak, was coughing, and had breathing difficulty on Oct 15, when she was hospitalized. However, she escaped just before she was to be transferred to a referral hospital and was found in a place of alternative healing the next day. Her condition deteriorated, and she died at home on Oct 17. Her 5-year-old daughter and 10-year-old son died Oct 9 and Oct 10, respectively, of H5N1 avian flu. Many poultry deaths had been recently reported in the family’s flocks and those of their neighbors. If the woman’s death is confirmed by the World Health Organization (WHO), it would bring Indonesia’s official H5N1 case count to 182, including 150 deaths.Oct 26 WHO report on children’s deathsStudy says T-cell response may help identify subclinical H5N1A research group from Oxford University exploring the prevalence of asymptomatic H5N1 avian influenza infections in an area of Vietnam that had experienced outbreaks found that T-cell interferon-gamma enzyme-linked immunosorbent spot (ELISPOT) assays could be a useful adjunct to serology, which has low sensitivity for detecting antibodies to the virus. They reported their findings in the Journal of Infectious Diseases. They obtained 747 blood samples from a community in northern Vietnam that had reported poultry outbreaks and human infections over the past decade. For a control group, they obtained serum samples from patients in the United Kingdom, as well an area of Vietnam where the virus has not been known to circulate. Twenty four (3.2%) participants in the exposed community had responses to the H5 hemagglutinin peptide pool, with little or no response to H1 or H3. They confirmed the responses by culturing ELISPOT assays and growing antigen-specific short-term T-cell lines and clones. Nearly 5% (37) of participants had antibody titers suggestive of H5N1 exposure. Only four had evidence exposure on both tests. The group concluded that although ELISPOT testing may be useful, more research is needed with cohorts in different geographic areas. They also studied 19 recovered H5N1 patients, only 3 of whom (16%) had H5-specific T-cell responses. They say this may be so “because T-cell responses are short-lived, as seen with seasonal influenza, and it is not known how long specific H5 T-cell responses may persist.”Nov 11 J Infect Dis study abstractIn a commentary on the study in the same issue, Susan Epstein, PhD, with the US Food and Drug Administration’s cellular and gene therapy division, said the study raises compelling questions, such as whether or not asymptomatic infections with H5 viruses not well adapted to humans stimulate T-cell, but not antibody, responses. She wrote that T-cell testing is still too cumbersome and expensive for widespread screening, though it may be useful for certain diagnostic purposes, such as testing family contacts in transmission studies.Nov 11 J Infect Dis commentary extractNewspaper report raises questions about contract for smallpox drugA Los Angeles Times report published yesterday has raised questions about the US government’s handling of a $433 million contract awarded in May to Siga Technologies Inc. for an antiviral to treat smallpox, saying the price of $255 per dose is well above what federal officials earlier said was reasonable. Siga announced in October 2010 that the Department of Health and Human Services (HHS) intended to give it a contract worth up to $2.8 billion for its drug, ST-246. But the contract required that the winner be a small business, and Chimerix Inc., maker of a competing antiviral, protested, saying Siga was too big, according to the Times report. The federal Small Business Administration agreed, but the Obama administration decided to block all firms except Siga from bidding for the contract, asserting that it was the only firm capable of delivering a product within 5 years. The final contract for 1.7 million doses of ST-246 was awarded in May, after negotiations described as contentious. The story said that in March, Dr. Richard Hatchett, chief medical officer for HHS’s Biomedical Advanced Research and Development Agency, complained that Siga’s projected profit on the product at that point was 180%, which he considered “outrageous.” In April, after Siga complained about HHS’s approach to profit, Dr. Nicole Lurie, HHS assistant secretary for preparedness and response, replaced the lead HHS negotiator on the deal, according to the story. Lurie told the Times that the contract was awarded strictly on merit. The story also says that billionaire Ronald O. Perelman, Siga’s controlling shareholder, is a longtime Democratic Party donor. In addition, the report raises questions about the need for the drug, noting that the government has enough smallpox vaccine for the entire population. The vaccine is regarded as likely to provide some protection if given within 4 days after exposure to the virus.Nov 13 LA Times storyJun 29 CIDRAP News item about change in Siga contractFeb 16 CIDRAP News item about contract award to ChimerixAnalysis shows diversity of swine-origin flu in humansUS swine-origin influenza viruses (SOIVs) collected from humans over the past two decades have been antigenically and genetically diverse, with only triple-reassortant SOIVs occurring since 1998, according to a study in Virology. Researchers analyzed 27 cases of SOIV reported to the Centers for Disease Control and Prevention from 1990 through 2010. All 6 of the viruses isolated from 1990 through 1995 were categorized as classical SOIVs, whereas all 21 isolated since 1998 have been triple-reassortant SOIVs. Of those 21, 13 were classified as H1N1, 1 as H1N2, and 7 as H3N2. The authors say the SOIVs were antigenically and genetically closely related to flu viruses circulating in pigs but not to those circulating in people. They write that their findings highlight “the importance of continued surveillance at the animal-human interface.” Their analysis did not include eight US cases identified since September of human infections with H3N2 SOIVs that contain genetic material from the 2009 H1N1 flu virus.Nov 10 Virol abstract
Guyana and Trinidad and Tobago take titles: CARICOM 10KGuyanese Cleveland Forde and Trinidadian Tonya Nero made it two in a row when they retained their male and female titles respectively in the 2015 edition of the CARICOM 10K race held in Bridgetown Barbados, Sunday 28 June 2015. Forde followed up his 2014 win with victory in a close…June 29, 2015In “Barbados”CARICOM 10K runs off on Sunday in BarbadosAmateur and professional athletes from across the Caribbean Community (CARICOM) will meet early Sunday (28 June) to compete in the Eleventh Annual CARICOM 10K Road Race on Bay Street Esplanade, Barbados. A much anticipated feature ahead of the Regular Meeting of the Conference of CARICOM Heads of Government, this edition…June 25, 2015In “Anguilla”Mark! Set! Go! CARICOM 10k Race to be held 3 JulyThe twelfth Annual CARICOM 10K race will be held on Sunday, 3 July, 2016, at 6:00 am in Georgetown, Guyana. The event will be held under the Theme ‘Promoting Healthy and Peaceful Societies’. The race is held to coincide with the Regular Meeting of the Conference of Heads of Government of…June 13, 2016In “Antigua & Barbuda”Share this on WhatsApp You may be interested in… CARICOM 10k races off on Sunday morning Of special note were the two eldest participants in the 10k and 5k races Mr. Franklin Archer and Mr Phillip Beckles, both of Guyana, who completed their races with commendation. There were four participants in the 1500 m race for schools and the youngest participant was Jalani Cheddi. The winner in that category was Ezekiel DeSouza, while second and third went to Khelani Glen and Jeremiah Harrison respectively. The event was attended by CARICOM Chairman and Prime Minister of Dominica Hon. Roosevelt Skerritt, Secretary General of CARICOM Ambassador Irwin LaRocque and Minister in the Ministry of Sports, Guyana, Hon. Nicolette Henry. In his remarks at the awards presentation ceremony Prime Minister Skerritt commended all of the participants for their efforts. He said physical activity was critically important within the Region which continued to deal with the challenges of Chronic Non-Communicable Diseases (CNCDs). He also commended the CARICOM Secretariat for including all levels of society in the event. All levels of society need to be involved in physical activity to prevent CNCDs,” Prime Minister Skerritt said. Secretary-General LaRocque in his remarks said everyone who participated was a winner. He also used the opportunity to thank the sponsors and partners which included Digicel Guyana, Courts Guyana, Demerara Distillers Limited, Eureka Laboratories, CARICOM Rice Mills Limited, the Guyana Athletics Association, Guyana Ministry of Sports, Guyana Defence Force, Guyana Police Force, Guyana Ministry of Public Health, Guyana Ministry of Public Infrastructure and the Guyana City Engineers. Guyana’s Minister of Sports, Hon Nicolette Henry said it was wonderful to see the high number of participants. She said those who participated were examples of how commitment and dedication paid off for health and well-being. The race was held to coincide with the 37th Regular Meeting of the Conference of CARICOM Heads of Government which will be held in Georgetown, Guyana, 4-6 July. The opening ceremony will be held tomorrow at the National Cultural Centre at 5:00 p.m. Share this:PrintTwitterFacebookLinkedInLike this:Like Loading… Jun 28, 2019 Jul 6, 2018 Jul 21, 2017 UN SG lauds CARICOM leadership on global issues CARICOM Road Race on 7 July This was the twelfth staging of the CARICOM 10k race which was held under the theme ‘Promoting Healthy and Peaceful Societies’. The start line was the CARICOM Secretariat, while the end point was the National Park where a presentation ceremony was held. In addition to the main event, there were three supporting events – a 5K race, a 1500m race for schools, and a special race for athletes with disabilities. The first place male winner in the 5k race was Ricky Williams, while second and third went to Tyrese Yensen and Joel Williams respectively. All three athletes were from Guyana. In the female category first place went to Joana Archer second place to Tabitha Benman and third to Kissanna Glen, all from Guyana. Athletes pose for a photograph outside the CARICOM Secretariat before the race on Sunday morning CARICOM 10k winners Cleveland Forde from Guyana and Linda McDonalnd from St. Vincent and the Grenadines pose for a photo with Minister in the Ministry of Sports, Guyana, Hon. Nicolette Henry. CARICOM Chairman and Prime Minister of Dominica, Hon. Roosevelt Skerritt, and Secretary-General of CARICOM Ambassador Irwin LaRocque after the twelfth staging of the event on Sunday July 3, 2016. Four-time CARICOM 10k winner Cleveland Forde of Guyana copped his fifth title in the latest edition of the CARICOM 10k Race on Sunday morning (July 3) in his native Guyana. He completed the race in 32:39 minutes. Linda McDonald brought victory to St. Vincent and the Grenadines in the female category with a time of 37:57. The second place in the male category went to Curtis Cox of Trinidad and Tobago clocking in at 32:56 while Winston Missingher of Guyana raced to third place with a time of 33:28. Second place for the females went to Euleen Josiah-Tanner from Guyana who finished at 39:46 and Guyanese Andrea Foster got third place with a time of 40:37. Sep 22, 2017 Health checks for CARICOM staff members during Caribbean…
To access this article REGISTER NOWWould you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week. Would you like to read more?Register for free to finish this article.Sign up now for the following benefits:Four FREE articles of your choice per monthBreaking news, comment and analysis from industry experts as it happensChoose from our portfolio of email newsletters
This will mark the 8th year of bacteria monitoring at Kenai North and Kenai South beaches. Water quality samples will be collected weekly at the two beach sites. The testing is done in order to evaluate background levels of bacteria before, during and after the fishery season to determine progress towards meeting water quality standards. Sampling along the Kenai River coastal beaches has indicated that bacteria levels frequently exceed acceptable levels. Testing indicates that the predominant source of bacteria is gulls. The council agreed to amend the ordinance to reflect this new amount. After being amended, the ordinance passed unanimously. FacebookTwitterEmailPrintFriendly分享The Kenai City Council unanimously approved amending grant funds for the amount allotted for sampling at the mouth of the Kenai River, which is required to build an adequate database for future modeling efforts and will be provided through a cooperative agreement with the Kenai Watershed Forum. Ordinance No. 3143-2020 was drafted to add an additional $34,216 to the existing sampling grant. Maggie Harings, environmental scientist with the Kenai Watershed Forum, announced that the amount had changed slightly: “I was informed literally during this meeting that the new amendment total would be $34,254, which brings the overall grant total – the new total for the entire grant – to $121,573.” The majority of exceedances are at beach sites downstream of a gull rookery, while a small number of exceedances occur near the gull rookery sites. Department of Environmental Conservation regulations and policies state that water quality standards in a water body may only be exceeded as a result of human actions, therefore DEC does not list a water body as “impaired” for natural conditions.